Jump to content
Sclero Forums
Sign in to follow this  
Joelf

Screening for pulmonary arterial hypertension in patients with systemic sclerosis.

Recommended Posts

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival.

 

Compared with routine clinical practice, PAH detection programs in SSc are able to identify patients with milder forms of the disease, allowing earlier management. Humbert M. (PubMed) Arthritis rheumatologist. 2011 Jul 18. (Also see: PAH)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

The part of the article I liked was the improvement in survival time! The patients found through screening (earlier diagnosis), the 'detected' group went from one-, 3-, 5-, and 8-year survival rates were 75%, 31%, 25%, and 17%, (not routinely screened without demonstrable clinical symptoms) respectively, to 100%, 81%, 73%, and 64% in detected by earlier screening patients. That's an enormous jump and all to our benefit. It was a small study with a limited number of patients, but wow, if this is demonstrated in greater numbers, it would be truly wonderful.


Jeannie McClelland

(Retired) ISN Director of Support Services

(Retired) ISN Sclero Forums Manager

(Retired) ISN Blog Manager

(Retired) ISN Assistant News Guide

(Retired) ISN Artist

International Scleroderma Network

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×